@article{study2021-18854f0d,
  title   = {{FDA Grants Accelerated Approval for ADUHELM (aducanumab) as the First and Only Alzheimer's Disease Treatment to Address a Defining Pathology of the Disease}},
  journal = {U.S. Food and Drug Administration (announced via Biogen press release)},
  year    = {2021}
}